Fund profile by ISIN IE00BL0L0H60
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
Research First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation by ISIN IE00BL0L0H60: TER 0.60%, domicile Ireland, accumulating, and 1-year price performance +40.4%.
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| FBTU.L | LSE | USD | Ireland | €75K | 2,656 |
| FBT.MI | ETFP | EUR | Ireland | €57K | 2,010 |
| FBT.L | LSE | GBX | Ireland | €25K | 909 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund has no German listing, so a German broker may not offer it, or may route the order to a foreign venue. As of 2026-10-13.
Largest holdings
The 10 largest holdings make up 39.88% of the fund, which holds 30 positions in total. As of 2026-10-12.
| Holding | Symbol | Weight |
|---|---|---|
| Natera Inc | NTRA | 4.67% |
| Halozyme Therapeutics Inc | HALO | 4.42% |
| Illumina Inc | ILMN | 4.38% |
| Repligen Corp | RGEN | 4.06% |
| NeoGenomics Inc | NEO | 3.97% |
| Corcept Therapeutics Inc | CORT | 3.83% |
| Genmab AS ADR | GMAB | 3.75% |
| BeOne Medicines Ltd ADR | ONC | 3.74% |
| Amgen Inc | AMGN | 3.54% |
| Gilead Sciences Inc | GILD | 3.50% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.